Search research articles
Contact Us
Filters
Showing results (91-100 of 116) with videos related to
Page
of 12
Sort By:
Lancet (London, England)
|
October 1, 1983
Cortical cholinergic deficit in mentally impaired Parkinsonian patients
R H Perry, B E Tomlinson, J M Candy, et al.
Neuroscience Letters
|
October 26, 1984
Cortical serotonin-S2 receptor binding abnormalities in patients with Alzheimer's disease: comparisons with Parkinson's disease
E K Perry, R H Perry, J M Candy, et al.
European Journal of Pharmacology
|
June 26, 1987
Autoradiographic visualization of binding sites for [3H]somatostatin in the rat brain
C A Whitford, J M Candy, C R Snell, et al.
Biology of the Cell
|
January 1, 1992
The imaging and quantification of aluminium in the human brain using dynamic secondary ion mass spectrometry (SIMS)
J M Candy, A E Oakley, S A Mountfort, et al.
Lancet (London, England)
|
August 13, 1994
Protective effect of apoE epsilon 2 in Alzheimer's disease
R Benjamin, A Leake, F K McArthur, et al.
Advances in Neurology
|
January 1, 1990
Role for aluminum and silicon in the pathogenesis of senile plaques: studies in chronic renal dialysis
J A Edwardson, A E Oakley, G A Taylor, et al.
Journal of the Neurological Sciences
|
October 1, 1984
Chromatographic characterization of neuropeptides in post mortem human brain
J A Biggins, J R McDermott, A I Smith, et al.
Neuroscience Letters
|
July 27, 1984
N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) affects locomotor activity without producing a nigrostriatal lesion in the rat
A Sahgal, J S Andrews, J A Biggins, et al.
Neuroscience Letters
|
October 24, 1985
Evidence for the early prenatal development of cortical cholinergic afferents from the nucleus of Meynert in the human foetus
J M Candy, E K Perry, R H Perry, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
June 1, 1987
Nicotinic receptor abnormalities in Alzheimer's and Parkinson's diseases
E K Perry, R H Perry, C J Smith, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 116) with videos related to
Sort By:
Page
of 12
Lancet (London, England)
|
October 1, 1983
Cortical cholinergic deficit in mentally impaired Parkinsonian patients
R H Perry, B E Tomlinson, J M Candy, et al.
Neuroscience Letters
|
October 26, 1984
Cortical serotonin-S2 receptor binding abnormalities in patients with Alzheimer's disease: comparisons with Parkinson's disease
E K Perry, R H Perry, J M Candy, et al.
European Journal of Pharmacology
|
June 26, 1987
Autoradiographic visualization of binding sites for [3H]somatostatin in the rat brain
C A Whitford, J M Candy, C R Snell, et al.
Biology of the Cell
|
January 1, 1992
The imaging and quantification of aluminium in the human brain using dynamic secondary ion mass spectrometry (SIMS)
J M Candy, A E Oakley, S A Mountfort, et al.
Lancet (London, England)
|
August 13, 1994
Protective effect of apoE epsilon 2 in Alzheimer's disease
R Benjamin, A Leake, F K McArthur, et al.
Advances in Neurology
|
January 1, 1990
Role for aluminum and silicon in the pathogenesis of senile plaques: studies in chronic renal dialysis
J A Edwardson, A E Oakley, G A Taylor, et al.
Journal of the Neurological Sciences
|
October 1, 1984
Chromatographic characterization of neuropeptides in post mortem human brain
J A Biggins, J R McDermott, A I Smith, et al.
Neuroscience Letters
|
July 27, 1984
N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) affects locomotor activity without producing a nigrostriatal lesion in the rat
A Sahgal, J S Andrews, J A Biggins, et al.
Neuroscience Letters
|
October 24, 1985
Evidence for the early prenatal development of cortical cholinergic afferents from the nucleus of Meynert in the human foetus
J M Candy, E K Perry, R H Perry, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
June 1, 1987
Nicotinic receptor abnormalities in Alzheimer's and Parkinson's diseases
E K Perry, R H Perry, C J Smith, et al.
Page
of 12